TKTeppei Kawahara

Teppei Kawahara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Teppei Kawahara has a total of 78 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuo Shin-Ya

    National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan

    6 shared publications
  • Miho Izumikawa

    Japan Biological Informatics Consortium (JBIC) , 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, Japan

    4 shared publications
  • Hirofumi Kai

    Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Global Center for Natural Resources Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

    2 shared publications
  • Junko Hashimoto

    Japan Biological Informatics Consortium (JBIC) , 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, Japan

    2 shared publications
  • Mary Ann Suico

    Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Global Center for Natural Resources Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

    2 shared publications
  • Mikiyo Wada

    Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

    2 shared publications

Latest Publications

  • Benastatin K, a chlorinated benastatin-related antibiotic from Streptomyces sp. HGTA384

    by Teppei Kawahara, Kanako Saita, Rika Iwamoto, Mikiyo Wada

    Benastatin K (1), a new chlorinated benastatin derivative, was isolated from the culture broth of the actinomycete Streptomyces sp. HGTA384. The structure of 1 was determined on the basis of spectroscopic analysis, including 1D and 2D NMR, as well as HRESI-MS, UV and IR, and comparison with data reported in the literature. Compound 1 and benastatins A and B exhibited inhibitory activity against Micrococcus luteus (MIC 7.8, 31.3, and 3.9 μM, respectively), and IgE-mediated β-hexosaminidase release in RBL-2H3 cells with IC50 values of 42, 79, and 19 μM, respectively.


  • A new linear peptide, higapeptin, isolated from the mud flat-derived fungus Acremonium persicinum inhibits mitochondrial energy metabolism

    by Ahmed H. El-Desoky, Yuki Hitora, Yoshitomo Nishime, Yusaku Sadahiro, Teppei Kawahara, Sachiko Tsukamoto

    A combination of LC–MS/MS and feature-based molecular networking analyses led to the isolation of a new adenopeptin analog, higapeptin (1), and four known peptides, adenopeptin (2), adenopeptins B and C (3 and 4), and acremopeptin (5), from the rice culture of the fungus Acremonium persicinum (18F04103) isolated from a mud flat of the Ariake Sea in Kyushu, Japan. The structure of 1 was determined by NMR and MS/MS fragmentation analyses. The absolute configuration of the constituent amino acids was determined by Marfey’s analysis after acid hydrolysis. The C-terminal residue was synthesized, and its absolute configuration was established by Marfey’s analysis. Compounds 1 and 2 were found to inhibit mitochondrial energy metabolism, similar to efrapeptin D (6), a known mitochondrial ATPase inhibitor. Graphical abstract


  • Effects of diet on the biological activities and content of functional components of silkworm Bombyx mori and its faeces

    by Y. Tagawa, T. Kawahara, S. Kotani, M. Wada

    Silkworm, Bombyx mori, and its faeces are notable healthy foods because of their biologically active components originating from mulberry (Morus spp.) leaves. However, in modern sericulture, silkworms are reared on artificial diet made primarily from defatted soybeans and dried mulberry leaf powder throughout the year. Neither the contents of functional components nor the biological activities of silkworms and their faeces raised on artificial diet have been investigated. Therefore, 1-deoxynojirimycin (DNJ) content, α-glucosidase inhibitory activity, Trolox equivalent antioxidant capacity (TEAC), total phenolic, total flavonoid and chlorophyll content were evaluated in silkworms and their faeces reared on mulberry leaves, artificial diet and then artificial diet switched to mulberry leaf from the fifth instar for four days. The DNJ content of silkworms depended on that in their diet and was significantly lower in silkworms fed with artificial diet than in those fed with mulberry leaves similar to the α-glucosidase inhibitory activity. On the contrary, TEAC, total phenolic content and total flavonoid content were similar in all silkworms regardless of feeding conditions. In the faeces of the artificial diet-reared group, TEAC, total phenolic content and total flavonoid content were significantly higher than those of the mulberry leaf-reared group. Chlorophyll content in faeces depended on the content of diet, whereas that in silkworms was low regardless of the diet type. The biological activities and contents of functional compounds in the artificial diet-reared group were at similar levels with those of the mulberry leaf-reared group when the diet switched to mulberry leaf from the first day of the fifth instar for four days, indicating that the biological activities and content of functional components in silkworms and its faeces are defined by diet and changeable over a short period.


  • Amamine, an isoquinoline alkaloid from the Kitasatospora sp. HGTA304

    by Teppei Kawahara, Marin Ueda, Naoki Kishimoto, Tae Yasutake, Shogo Misumi, Hari Prasad Devkota, Mikiyo Wada

    Amamine (1), a new isoquinoline alkaloid, was isolated from the culture extract of an actinomycete Kitasatospora sp. HGTA304. The structure of 1 was determined by NMR and MS analyses in combination with UV data. Compound 1 displayed α-glucosidase inhibitory potential (IC50 value of 56 μM) compared with acarbose (IC50 value of 549 μM) as standard.


  • Open Access

    CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion

    by Jun Kuwazuru, Mary Ann Suico, Kohei Omachi, Haruka Kojima, Misato Kamura, Shota Kaseda, Teppei Kawahara, Yuki Hitora, Hikaru Kato, Sachiko Tsukamoto, et al.

    Key Points: Screening of natural product extracts to find candidate compounds that increase mutant type IV collagen α3,4,5 (α345(IV)) trimer secretion in Alport syndrome (AS). Cyclosporin A (CsA) and alisporivir (ALV) increase mutant α345(IV) trimer secretion in AS. PPIF/cyclophilin D mediates the effect of CsA and ALV on mutant trimer secretion. Background: Type IV collagen α3,4,5 (α345(IV)) is an obligate trimer that is secreted to form a collagen network, which is the structural foundation of basement membrane. Mutation in one of the genes (COL4A3, A4, A5) encoding these proteins underlies the progressive genetic nephropathy Alport syndrome (AS) due to deficiency in trimerization and/or secretion of the α345(IV) trimer. Thus, improving mutant α345(IV) trimerization and secretion could be a good therapeutic approach for AS. Methods: Using the nanoluciferase-based platform that we previously developed to detect α345(IV) formation and secretion in HEK293T cells, we screened libraries of natural product extracts and compounds to find a candidate compound capable of increasing mutant α345(IV) secretion. Results: The screening of >13,000 extracts and >600 compounds revealed that cyclosporin A (CsA) increased the secretion of mutant α345(IV)-G1244D. To elucidate the mechanism of the effect of CsA, we evaluated CsA derivatives with different ability to bind to calcineurin (Cn) and cyclophilin (Cyp). Alisporivir (ALV), which binds to Cyp but not to Cn, increased the trimer secretion of mutant α345(IV). Knockdown studies on Cyps showed that PPIF/cyclophilin D was involved in the trimer secretion-enhancing activity of CsA and ALV. We confirmed that other α345(IV) mutants are also responsive to CsA and ALV. Conclusions: CsA was previously reported to improve proteinuria in patients with AS, but owing to its nephrotoxic effect, CsA is not recommended for treatment in patients with AS. Our data raise the possibility that ALV could be a safer option than CsA. This study provides a novel therapeutic candidate for AS with an innovative mechanism of action and reveals an aspect of the intracellular regulatory mechanism of α345(IV) that was previously unexplored.


  • Open Access

    Transthyretin Amyloid Fibril Disrupting Activities of Extracts and Fractions from Juglans mandshurica Maxim. var. cordiformis (Makino) Kitam.

    by Niraj Chaudhary, Ryoko Sasaki, Tsuyoshi Shuto, Masato Watanabe, Teppei Kawahara, Mary Ann Suico, Takeshi Yokoyama, Mineyuki Mizuguchi, Hirofumi Kai, Hari Prasad Devkota

    Transthyretin-related amyloidosis is a slowly progressive disorder caused by deposition of insoluble amyloid plaques formed by fibrillization of mutant or defective transthyretin (TTR) monomers that leads to neurodegeneration and organ failure. Thus, any compound exhibiting TTR amyloid formation inhibitory activity or TTR amyloid fibril disrupting activity might be a potential candidate for the development of therapies for these disorders. Our aim in this study was the evaluation of the TTR amyloid fibril disrupting potential of extracts of leaves and immature fruits of two Juglans plants, i.e., Juglans mandshurica var. sachalinensis and Juglans mandshurica var. cordiformis. The TTR amyloid fibril disrupting activity was measured by Thioflavin-T (ThT) assay and PROTEOSTAT® Protein aggregation assay methods. A fifty percent acetone extract of the fruits of Juglans mandshurica var. cordiformis showed strong amyloid fibril disrupting activity, and was further fractionated using different solvents. Ethyl acetate and n-butanol fractions showed significant activity in both assays. Syringic acid was isolated and identified as main compound in both of these fractions; however, it did not show any activity. Furthermore, some of the previously reported compounds from Juglans plants including naphthoquinone derivatives and phenolic compounds were evaluated to identify the potential bioactive compounds. Among them, juglone, a naphthoquinone derivative showed promising activity. However, juglone also showed strong cytotoxicity in HEK293 cells. Thus, future studies should focus on the isolation and identification of naphthoquinone derivatives or other compounds from Juglans plan ts with potent bioactivity and low cytotoxicity.


  • Neothioviridamide, a Polythioamide Compound Produced by Heterologous Expression of a Streptomyces sp. Cryptic RiPP Biosynthetic Gene Cluster

    by Teppei Kawahara, Miho Izumikawa, Ikuko Kozone, Junko Hashimoto, Noritaka Kagaya, Hanae Koiwai, Mamoru Komatsu, Manabu Fujie, Noriyuki Sato, Haruo Ikeda, et al.

    During genome mining for thioviridamide-like biosynthetic gene clusters that could produce polythioamide RiPP (ribosomally synthesized and post-translationally modified peptides), we discovered a novel cryptic biosynthetic gene cluster. During efforts to express this biosynthetic gene using heterologous expression of this biosynthetic gene cluster, a novel compound designated as neothioviridamide was produced. We report herein the cloning and heterologous expression of the neothioviridamide biosynthetic gene cluster and the isolation, structure determination, and cytotoxic activity of neothioviridamide.


  • Open Access

    JBIR-150, a novel 20-membered polyene macrolactam from marine-derived Streptomyces sp. OPMA00071

    by Teppei Kawahara, Takeshi Fujiwara, Noritaka Kagaya, Kazuo Shin-Ya

    During the course of constructing a natural product library for drug screening consisting of microbial culture extracts originated from marine samples, we evaluated natural product components profiles via UPLC TOF-MS and routine biological tests for cytotoxic and antibiotic activities for all of the culture extract samples. By combination of chemical screening and biological activities, we succeeded in discovering a 20-membered macrolactam antibiotic subsequently designated JBIR-150 (1) from a marine-derived actinomycete identified as Streptomyces sp. that was isolated from an Okinawan marine sediment. The chemical structure of 1 was determined by interpreting NMR spectroscopic and mass spectrometric data. Compound 1 exhibited moderate cytotoxicity against MESO-1 and Jurkat cells.


  • Compound A inhibits urothelial tumorigenesis via both glucocorticoid receptor and androgen receptor pathways

    by H. Ide, S. Inoue, Y. Zheng, E. Kashiwagi, T. Kawahara, H. Miyamoto

  • Unveiling the Biosynthetic Pathway of the Ribosomally Synthesized and Post‐translationally Modified Peptide Ustiloxin B in Filamentous Fungi

    by Ying Ye, Atsushi Minami, Yuya Igarashi, Miho Izumikawa, Myco Umemura, Nozomi Nagano, Masayuki Machida, Teppei Kawahara, Kazuo Shin‐Ya, Katsuya Gomi, et al.